Articles related to BIOMARKERS

You could have a patient with an LDL-C of 100 mg/dL and think they’re in the clear, but if their LDL-P is sky-high, they’re still at risk for plaque formation.

p-Tau217 demonstrates superior diagnostic accuracy among fluid biomarkers for detecting amyloid beta pathology, offering a noninvasive approach to early Alzheimer’s detection.

Blood-based mitochondrial DNA testing could provide a less invasive alternative to spinal taps for Parkinson’s diagnosis, with implications for earlier intervention and treatment.

Latest clinical trial data suggests active monitoring may be a viable alternative to standard treatment for select low-risk DCIS patients, with comparable quality-of-life outcomes.

The multidisciplinary guidelines introduce blood-based biomarkers as key diagnostic tools, potentially reducing unnecessary CT scans while improving outcome predictions.

Nearly half of behavioral variant frontotemporal dementia patients initially receive a psychiatric diagnosis, highlighting the critical need for improved diagnostic approaches.